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Abstract
Background: Ageing is associated with dysfunction in the humoral response leading to decreased
protection against infectious diseases. Defects in T cell function due to age have been well
characterized but it is unclear if dysfunctions in antibody responses are due to deficiencies in a
helper environment or intrinsic B cell defects. Previous studies from our laboratory have shown
that aged B lymphocytes are able to differentiate into high affinity antibody-secreting cells at a
frequency similar to their young counterparts. However, expansion of B cells in vivo was reduced
in aged animals when compared to young.
Methods: To further investigate the cause of this reduced expansion, we have now examined early
activation events of aged B cells in response to anti-CD40 monoclonal antibody (mAb) and
lipopolysaccharide (LPS) stimulation in vitro. To do this spleen cells were harvested from young,
middle-aged and aged quasi-monoclonal (QM) mice and cultured in complete RPMI for 24 and 48
hours. Cultures contained either LPS or anti-CD40 mAb and murine IL-4. Cells were collected and
analyzed using flow cytometry. To examine the proliferative capacity of aged B cells spleen cells
were collected as before and cultured in 96 well microtiter plates with either LPS or anti-CD40
mAb and murine IL-4 for 24 hours. Tritiated thymidine ([3H]-Tdr) was added to each well and
incubated for another 24 hours after which cells were collected and analyzed using a scintillation
counter.
Results: Resting aged B cells exhibited similar levels of CD40 expression when compared to young
cells and efficiently up-regulated CD86 and CD69 and also down-regulated CD38 upon stimulation.
However, aged B cells proliferated less than young B cells and showed a consistent, but not
statistically significant, reduction in their ability to form blast cells.
Conclusion: Aged B cells exhibited a reduced response in some early activation events but
produced at least a partial response in all cases. Thus, therapeutic intervention may be possible,
despite intrinsically different responses in aged B cells.
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Background
Dysregulation of the humoral immune response has long
been associated with ageing, causing inefficient control of
many disease-causing microorganisms and cancers, and
leading to an increase in morbidity and mortality. These
changes are particularly seen in T cell-dependent (TD)
immune responses in which aged individuals have shown
poorer quality antibodies and lower antibody titers fol-
lowing immunization (reviewed in [1-4]). Similarly, in
aged rats following intraduodenal immunization, the
number of antigen-specific IgA-secreting cells in the intes-
tinal lamina propria is markedly diminished compared to
young animals [5]. However, the numbers of circulating B
cells or serum Ig levels are mostly maintained during age-
ing [6-9]. In fact, the overall number of mature B cells
does not seem to be affected by age despite a decline in the
number of pre-B cells produced in the bone marrow
[10,11]. Bromodeoxyuridine (BrdU) labeling of splenic B
cells also suggests an increase in the half-life of mature B
cells in aged mice [9]. Likewise, while antibody levels for
antigen-specific responses decrease with age, serum
immunoglobulin levels, particularly IgG and IgA are
reported to be increased [12]. The complexity of a TD
immune response and the many cells contributing to this
response (e.g. B cells, T cells, macrophages, follicular den-
dritic cells, etc.) has made it unclear how much of the age-
related dysfunction is due to poor helper environment
versus intrinsic B cell defects (reviewed in [4,13,14]).
The TD response is initiated in the germinal centers (GC)
where isotype-switching, memory cell generation, and
clonal expansion occur. This response is impaired in aged
animals leading to reduced B cell memory, antibody affin-
ity maturation, and the establishment of long-lived anti-
body-forming cells (AFCs) [15]. This dysfunction is also
reflected in a significant reduction in the number and size
of GC following immunization in aged animals [15-17].
Defects have also been reported in the antigen transport
mechanisms of follicular dendritic cells (FDC) [16,18,19].
A major function of FDC is to trap and retain antigens,
and the development of the FDC-reticulum facilitates the
germinal center reaction. Aged mice show a decrease in
FDC size and a reduction in numbers of FDC-reticula. Evi-
dence has been found for the requirement of FDC for ger-
minal center formation and thus a decrease in FDC
number and size has been associated with a reduced
number of germinal centers [16,20].
Successful GC reactions require the interaction of the cell
surface protein CD40 with its ligand CD154. CD40 is
expressed on virtually all mature B cells as well as a variety
of other APCs. This protein plays a key role in the initia-
tion of adaptive immune responses through its interac-
tion with CD154 expressed on activated CD4+ helper T
cells (reviewed in [21,22]). Moreover, CD40 mediates
multiple biological activities including B cell prolifera-
tion, affinity maturation, GC development, rescue of GC
B cells from apoptosis, and memory B cell development
[23,24]. Whether or not levels of CD40/CD154 expres-
sion decrease with age is under debate. It has been
reported that there are no age-related decreases in the
expression of CD40 on murine splenic cells [8]. However,
other reports show that aged human peripheral blood
cells have decreased levels of CD40/CD154, while human
tonsillar lymphocytes show no significant change in the
expression of CD40 due to age [25-27]. Although age-
related changes in CD40/CD154 expression or function
could contribute to a poor primary and secondary TD
response, it is unclear, based on the in situ differences in
these studies, whether or not age negatively impacts the
immune response through decreased expression or func-
tion of CD40/CD154.
In adoptive transfer studies, B cells from aged animals
were found to be competent to mount a high affinity, iso-
type-switched response to TD antigens when an appropri-
ate helper environment was provided in vivo [4,28]. Using
severe combined immunodeficient (SCID) mice as recipi-
ents, Yang et al. [28] have shown that antibodies pro-
duced by young B cells, when paired with aged T cells,
have an altered rate of somatic mutation and VH gene
usage. When aged B cells were transferred with young T
cells into the SCID environment, however, somatic muta-
tions still failed to accumulate normally suggesting intrin-
sic B cell defects due to age [28]. Previous results from our
lab [29] likewise found that upon transfer to young, intact
recipients, aged B cells were able to produce a germinal
center response, but were unable to expand to the extent
of their young counterparts during the primary GC
response. It is unclear, however, whether the reduction in
expansion was the result of decreased proliferation of the
cells within the GC or decreased trafficking to the spleen
from blood or other organs [29]. An age-related decrease
in migration has been previously noted for lymphocyte
migration from the mesenteric lymph nodes to the intes-
tinal lamina propria [30]. A closer look at the decrease in
lymphocyte homing has revealed a decrease in the expres-
sion of α4β7 and MAdCAM-1, critical markers for homing
[31].
To further investigate early activation of aged cells in
response to antigenic stimulation, in vitro studies were
performed. While levels of CD40 were similar on resting
aged and young B cells, aged B cells showed a reduced
ability to proliferate in response to both anti-CD40 and
LPS stimulation. Aged B cells were able to form blast cells
upon stimulation, but showed a consistent, but not statis-
tically significant reduction in blast formation. Surpris-
ingly, the induced expression of the early activation
markers CD86, CD69 and CD38 up- and down-regula-Immunity & Ageing 2008, 5:15 http://www.immunityageing.com/content/5/1/15
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tion were found to be normal in aged B cells. In all cases
aged B cells produced at least a partial response to stimu-
lation indicating the possibility of improving immunity
in the elderly through therapeutic intervention.
Results
CD40 expression is equivalent on young and aged freshly 
isolated B cells
Age-associated changes in the function or expression of
CD40 and CD154 may provide insight to signaling dys-
function within aged B cells. However, there are several
contradictory reports concerning the effects of ageing on
CD40 expression in B cells [8,25,27], therefore, freshly
isolated B cells from young and aged quasi-monoclonal
(QM) and C57BL/6 mice were compared for CD40
expression (Figure 1). Both young and aged mice of both
strains showed similar levels of CD40 on B220+ B cells,
indicating no age-related difference (A and B). Also, for
the QM mice, B220+ cells were further analyzed for CD40
expression based on nitrophenyl (NP) – specificity (C and
D). As QM mice age, environmental pressures cause the
NP-specific B cell populations to undergo V(D)J gene rear-
rangement and lose specificity for NP [32]. As these cells
may have been "antigen-experienced", they may exhibit
different levels of CD40. As seen in Figure 1C, QM mice
show 42% of the total B220+ splenocyte population is NP-
while the young QM show only 18% of the B220+ popu-
lation to be NP- as expected [33,29]. Upon gating the
B220+/NP+ or NP- cells, there was no difference in CD40
expression between aged and young B cells (Fig. 1D).
Additional phenotyping (CD69, CD86, CD38, PNA, GL-
7, MHCII and CD23: data not shown) of the aged cells
was also performed to ensure starting B cell populations
were similar. Therefore, both aged and young B cells from
normal and transgenic mice express equivalent levels of
CD40 and exhibit a resting phenotype.
Aged B cells express activation markers upon stimulation 
at a similar level to young B cells
Although levels of CD40 are not affected by ageing, the
signaling pathway in aged B cells could be dysfunctional
leading to a defect in regulation of early activation mark-
ers including CD86, CD69 and CD38. Young and aged
freshly isolated QM splenocytes were cultured with media
only, LPS, or anti-CD40 mAb with murine IL-4 (inter-
leukin-4) to stimulate B cells in a T cell-independent (TI)
and TD manner, respectively. In vitro cultures were incu-
bated for 24 and 48 hours then harvested and stained with
anti-B220 mAb and one of the following: anti-CD38
mAb, anti-CD86 mAb and anti-CD69 mAb. As shown in
Figure 2, splenocytes of all ages were able to upregulate
CD86 expression with either stimulus compared to
media. Further examination found that both aged and
young lymphocytes are also able to effectively upregulate
CD69 and down-regulate CD38 upon stimulation with
LPS and anti-CD40 mAb (Figure 3). Thus, early regulation
of these surface markers appears to be intact in aged B
cells.
Aged B cells form blasts upon stimulation with LPS and 
anti-CD40 mAb
Another early sign of B cell activation is the formation of
blast cells. Splenocytes from young and aged QM mice
were cultured for 24 and 48 hrs with media only, LPS, or
anti-CD40 mAb as above. Analysis of cells was done using
flow cytometry to identify blasts based on forward and
side scatter. An increase in blast formation was seen
between 24 and 48 hrs for all ages when stimulating con-
ditions were added (Figure 4), thus aged B cells were not
intrinsically unable to form blasts. Notably, some individ-
ual aged mice (about 1:4 individuals) showed more blast
formation when grown in media alone than did young
cells (Table 1), so for this reason, background percentages
from media only were divided into each of the stimulating
conditions to yield "fold increase" of blasts induced
through stimulating conditions (Figure 5 and Table 1).
Even accounting for increased blast formation in media
alone, aged B cells were able to produce blasts under stim-
ulating conditions. Interestingly, a consistent, but not sig-
nificant, trend of lower antigen-induced responses in the
aged cells was observed.
Aged B cells show a decreased proliferation upon 
stimulation with LPS and anti-CD40 mAb
Since blasts are formed prior to cell division, we consid-
ered that perhaps this trend of lower blast cell formation
would have consequences in the ability of aged B cells to
proliferate. Freshly isolated splenocytes from QM young
and aged mice were cultured under stimulating condi-
tions (LPS or anti-CD40 mAb) for 48 hours. Cells were
allowed to incorporate [3H]-Tdr for 24 hours prior to har-
vest. Results indicate no significant difference between
aged and young B cells when cultured in media (P > 0.05)
(Figure 6). As predicted, however, aged B cells show a sig-
nificant decrease in their proliferative capability in both
LPS and anti-CD40 mAb stimulated cultures (P = 0.005
and 0.029 respectively). Middle-aged B cells also show a
significant decrease in their ability to proliferate when
stimulated with LPS (P = 0.031). A slight decrease was
noted between middle-aged and young B cells when stim-
ulated with anti-CD40 mAb but the difference was not sig-
nificant. Thus, while aged B cells were able to respond to
stimuli and proliferated above media levels, they were not
as effective as young B cells.
Discussion
Previous data from our lab has suggested that aged B cells
were capable of undergoing normal activation events in
vivo including germinal center reactions, but were defec-
tive in expansion following TD stimulation [29]. To inves-Immunity & Ageing 2008, 5:15 http://www.immunityageing.com/content/5/1/15
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CD40 levels are similar on freshly isolated B cells from normal and Tg animals Figure 1
CD40 levels are similar on freshly isolated B cells from normal and Tg animals. Freshly isolated SPC from young 
and aged C57 (A and B) and QM (C-G) mice, were stained with anti-CD40 mAb along with anti-B220 and NP-PE. Percentages 
of B220+ lymphocytes are shown in (A) and (C), and CD40 expression (B and D) was determined for the B220+ population. 
Percentages of NP-specific QM B cells and non-NP binding cells are shown in E. The levels of CD40 on NP- and NP+/B220+ 
cells are shown in (F) and (G). Thin lines indicate cells from young animals and thick lines indicate cells from aged animals. Rep-
resentative of 3 separate experiments.
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Splenocytes from aged mice are able to upregulate CD86 effectively upon stimulation Figure 2
Splenocytes from aged mice are able to upregulate CD86 effectively upon stimulation. SPC from young, middle-
aged, and aged QM mice were harvested and cultured for 24 and 48 hours. Splenocytes were stained for expression of cell sur-
face markers. Lymphocytes were gated on FSC/SSC and B cells on B220+. Representative of 4 separate experiments.
B cells from aged mice regulate surface marker expression similar to those from young mice Figure 3
B cells from aged mice regulate surface marker expression similar to those from young mice. SPC from young 
and aged QM mice were harvested and cultured with LPS or anti-CD40 with IL-4 for 48 hours. Splenocytes were stained for 
expression of cell surface markers. Lymphocytes were gated on FSC/SSC and B cells on B220+. Data are representative of 4 
separate experiments.Immunity & Ageing 2008, 5:15 http://www.immunityageing.com/content/5/1/15
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tigate this further, lymphocytes were cultured in vitro with
LPS to induce a TI response or anti-CD40 mAb to induce
a TD response. Their ability to express activation markers,
form blasts and proliferate was examined. Aged B cells
were found to be dysfunctional in their ability to prolifer-
ate but were able to appropriately regulate expression of
activation markers. Importantly, in all cases, stimulated
aged B cells always showed a response above unstimu-
lated cells suggesting some function is retained.
Song et al. [8] have reported that aged splenocytes appear
to be comparable in expression and function of CD40 to
their young counterparts while it has also been noted that
the proportion of CD40+ resting B cells remains relatively
stable during ageing [8,27]. Contrary to these findings is
the report by Lio et al. [25] in which aged peripheral
blood mononuclear cells (PBMNC) showed reduced
expression of CD40 and CD40L. It is unclear if this dis-
crepancy is due to differences in microenvironment or
age-related dysfunction. Our previous in vivo experiments
utilized B cells from Ig transgenic (QM) mice containing
a targeted gene insertion that allows the NP-specific B cells
to retain the ability to participate in germinal center reac-
tions [29,33,34]. The NP hapten is not an environmental
antigen, thus aged QM mice contain a large population of
antigen-inexperienced cells [33]. Due to environmental
Table 1: Aged B cells are able to form blast cells after 48 hours.
Media LPS Anti-CD40
% Blast Formation Fold-increase % Blast Formation Fold-increase % Blast Formation Fold-increase
E x p e r i m e n t  1 Y o u n g 7_ _ 5 282 54
Aged 10 __ 50 5 24 3
Experiment 2 Young 10 __ 71 7 32 3
Aged 20 __ 68 3 38 2
SPC from young and aged mice were harvested and cultured for 48 hours in media only, LPS, or anti-CD40 mab with murine IL-4. Blast cells were 
gated as in figure 5 and percent blast cells were calculated. Percent of blasts from stimulating conditions were divided by percent of blast cells in 
media only to produce a fold-increase. Data is representative of 3 separate experiments.
Aged B cells are able to produce blast cells when stimulated with LPS Figure 4
Aged B cells are able to produce blast cells when stimulated with LPS. SPC were harvested from young, middle-aged, 
and aged QM mice and cultured for 24 and 48 hours in stimulating conditions (LPS) and analyzed for side and forward scatter 
by flow cytometry. Data are representative of 4 experiments.Immunity & Ageing 2008, 5:15 http://www.immunityageing.com/content/5/1/15
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pressure, however, aged QM mice also develop a popula-
tion of non-transgenic Tg cells derived from VH gene
replacements which allowed us to observe both naïve and
potentially antigen-experienced cells [32]. Because of the
transgenic nature of the QM mice, all experiments were
also conducted using normal C57 mice and no differences
were noted between normal and transgenic mice. Our
results showed equivalent expression of CD40 on all B
cells examined. Thus, any age-associated dysregulation
due to a defect within the CD40/CD154 interaction could
not be attributed merely to a decrease in surface expres-
sion of the CD40 molecule.
To examine the functional consequences of engaging
CD40, the ability of aged B cells to up or down-regulate
early activation markers (CD86, CD69 and CD38) was
tested. Our data suggest that cultured, aged murine B cells
are responsive to stimulation, both LPS and CD40, with
normal upregulation of CD86 and CD69 and down-regu-
lation of CD38. It has been suggested that splenic B cells
from aged GC of C57BL/6 mice lack CD86, however, this
observation may be attributed to the poor T cell help pro-
vided in these experiments and not an intrinsic defect in
the aged cells' ability to express this protein [35]. Another
study, using aged B6D2F1 mice, showed that B cells from
the GCs of Peyer's patches have normal expression of
CD86 [36]. These reported differences in CD86 expres-
sion may be attributed to differences in experimental set-
up including different strains of mice, immunization pro-
tocols and tissues used. Similar observations have been
made with the expression of CD69. It has been noted that
expression of CD69 on γδT lymphocytes is increased in
elderly [37] while Herndandez-Garcia et al. found that
expression of CD69 on peripheral blood lymphocytes in
elderly was no different than in young [38].
Another early activation event induced by stimulation is
the formation of blasts. We have found that aged B cells
form blasts in response to LPS or anti-CD40 stimulation
in all cases, however there was a consistent trend toward a
lower percentage of induced blast cells. Unexpectedly,
cells from individual aged donors cultured in medium
Aged B cells are able to effectively produce blast cells in response to stimulation Figure 5
Aged B cells are able to effectively produce blast cells in response to stimulation. SPC from young and aged QM 
mice were harvested and cultured for 48 hours. Blast cells were gated using FSC/SSC. Percentage of blast cells in media were 
divided into percentages of blast cells for each stimulating condition to give fold-increase as shown.Immunity & Ageing 2008, 5:15 http://www.immunityageing.com/content/5/1/15
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alone frequently (about 50% of the time) demonstrated
increased blast formation compared to young cells cul-
tured under the same conditions. It is unclear why indi-
vidual aged animals varied in this trait as there was no
correlation to specific age (for example we observed this
in both mice closer to 15 months and those closer to 19
months), gender (it occurred in both males and females),
and the mice were genetically identical.
Proliferation of B cells was significantly decreased in aged
animals. These data are consistent with studies showing
that the GC reactions in aged animals are reduced in
number and size [15,16]. It has been noted by Whisler et
al [39] that aged human peripheral blood B cells consist-
ently showed a 50% reduction in proliferation upon stim-
ulation with Staphylococcus aureus, while Song et al [8] has
shown that aged murine splenic cells cultured with anti-
CD40 mAb proliferated more robustly than their young
counterparts. The reasons for these differences are unclear.
The current results from both the blast and proliferation
assays indicate either the inability of aged B cells to
respond to stimulation or an increase in apoptosis follow-
ing stimulation. It is possible that aged and young cells
undergo equal rounds of division but apoptosis may be
induced more frequently in the aged cells. It will be of
interest in future studies to examine the impact of
decreased proliferative ability following primary antigen
exposure on secondary antibody responses.
Conclusion
The mechanisms of immune dysfunction in the elderly
are unclear and an understanding of this dysfunction is
becoming increasingly important as the average lifespan
reaches record levels. We have shown that aged B cells are
intrinsically dysfunctional and contribute to ineffective
humoral immunity in the elderly. Other studies, particu-
larly in mucosal immunity, support the notion of early
activation defects, for example the proper homing to
effector sites [30,31]. Surprisingly, the early response from
aged B cells was not completely defective since, in all
cases, at least a partial response was seen. This observation
gives hope that effective therapies can be produced to help
increase antibody responses. With high morbidity and
Middle-aged and aged B cells show decreased ability to proliferate under stimulating conditions Figure 6
Middle-aged and aged B cells show decreased ability to proliferate under stimulating conditions. SPC from 
young, middle-aged, and aged QM mice were harvested and cultured in triplicate with anti-CD40 mAb or LPS for 24 hours and 
incubated with [3H]-Tdr and incubated another 24 hours. CPM was measured as described in material and methods. Error 
bars are shown for triplicate samples. Middle-aged and aged B cells stimulated with LPS show a significant decrease in prolifer-
ative capacity (P = 0.03 and 0.005 respectively). Aged B cells stimulated with LPS show a significant decrease (P = 0.029) while 
middle-aged cells appear to be decrease are not significantly different (P = 0.09). Data represents 4 experiments. P values 
determined by student's T-test.Immunity & Ageing 2008, 5:15 http://www.immunityageing.com/content/5/1/15
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mortality from infectious diseases, it is critical that age-
related defects in immune responses be identified.
Methods
Mice
C57BL/6 mice were obtained from the National Cancer
Institute (Bethesda, MD) and housed at Illinois State Uni-
versity's animal research facility under approval from the
Institutional Animal Care and Use Committee (Protocol
#3-2007). Quasi-monoclonal (QM) Ig-transgenic mice,
kindly supplied by M. Cascalho, were developed using
"knock-in" technology to produce a mouse with B cells
specific for nitrophenyl hapten (NP) [33]. QM mice were
backbred to the C57/BL6 JH
-/- Jk
-/- strain to produce QMF9.
Some QMF9 were bred for a single generation to C57BL/
6 to produce QMKappa mice. A breeding colony of each
strain is maintained at Illinois State University's animal
research facility. Animals used for these experiments were
either young (4–6 months), middle aged (11–13
months), or older (16–18 months).
Cell Cultures
Spleens were removed aseptically from young, middle-
aged, or aged QM mice and a single cell suspension was
prepared in RPMI 1640 (GibCo Invitrogen Corporation,
Brad Island, NY). Red blood cells were lysed with ACT
buffer (0.144 M NH4Cl and 0.017 M Tris, pH 7.2). Lym-
phocytes were cultured at 3 × 106 cells/well in 6 well cell
culture plates in CO2 incubator for 24–48 hours in com-
plete RPMI media (RPMI supplemented with 10% fetal
bovine serum (FBS; Hyclone; low endotoxin, low IgG),
Penicillin G, L-glutamine, Streptomycin, 2-Mercaptoetha-
nol, and 25 mM HEPES). Some cultures contained 50 μg/
ml Lipopolysaccharide from Escherichia coli K-235 (LPS,
Sigma Chemical, St. Louis, MO) or 10 μg/ml anti-CD40
mAb (1C10, Southern Biotechnology, Birmingham, AL)
and 40 U/ml murine IL-4 (Peprotech, Rocky Hill, NJ).
In vitro proliferation
Spleens were prepared as described above and 2 × 105
RBC-depleted splenocytes were cultured in 96 well micro-
titer plates in CO2 incubator for 24 hours in complete
RPMI. Some cultures contained 50 μg/ml LPS or 10 μg/ml
1C10 and 20 U/ml murine IL-4. Tritiated thymidine
([3H]-Tdr) (1 μCi/well) was added and the cells were
incubated an additional 24 hours. Cells were harvested
through a PHD™ cell harvester (Cambridge Technology,
Inc., Cambridge, MA) and samples run on a Beckman
multi-purpose scintillation counter (Beckman Coulter,
Inc., Fullerton, CA).
Flow Cytometry
Freshly isolated or cultured cells were stained for flow
cytometric analysis with saturating dilutions of anti-B220
Cy-Chrome, anti-CD38 biotin (Pharmingen, San Diego,
CA), anti-CD69-PE, anti-CD86-FITC, streptavidin-PE
(Southern Biotechnology, Birmingham, AL), anti-Id-FITC
(kindly provided by T. Imanishi-Kari), or NP-PE (Biose-
arch Technologies, Novato, CA). Samples included 10%
normal rat serum to prevent non-specific binding. Cells
were analyzed immediately or fixed by adding 300 μl cold
0.5% paraformaldehyde in PBS and mixed thoroughly.
Samples were analyzed on a Becton Dickinson FACSCali-
bur flow cytometer using CellQuest Pro software (San
Jose, CA) with 10,000 events collected.
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